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Abstract
Background: We aimed to investigate the effects of ambient respiratory viral infections in the general population
on rheumatoid arthritis (RA) development.
Methods: Data of weekly incident RA (2012–2013) were obtained from the Korean National Health Insurance claims
database, and those of weekly observations on eight respiratory viral infections were obtained from the Korea
Centers for Disease Control and Prevention database. We estimated the percentage change in incident RA
associated with ambient mean respiratory viral infections using a generalized linear model, after adjusting for time
trend, air pollution, and meteorological data.
Results: A total of 24,117 cases of incident RA (mean age 54.7 years, 18,688 [77.5%] women) were analyzed.
Ambient respiratory viral infections in the population were associated with a higher number of incident RA over
time, and its effect peaked 6 or 7 weeks after exposure. Among the 8 viruses, parainfluenza virus (4.8% for 1%
respiratory viral infection increase, 95% CI 1.6 to 8.1, P = .003), coronavirus (9.2%, 3.9 to 14.8, P < .001), and
metapneumovirus (44%, 2.0 to 103.4, P = .038) were associated with increased number of incident RA. The impact of
these respiratory viral infections remained significant in women (3.8%, 12.1%, and 67.4%, respectively, P < .05) and in
older patients (10.7%, 14.6%, and 118.2%, respectively, P < .05).
Conclusions: Ambient respiratory viral infections in the population were associated with an increased number of
incident RA, especially in women and older patients, suggesting that respiratory viral infections can be a novel
environmental risk factor for the development of RA.
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Introduction
Rheumatoid arthritis (RA) is an immune-mediated disease
involving interactions between genetic and environmental
factors [1, 2]. It has been considered that a pre-clinical RA
phase comprising the generation of autoantibodies in gen-
etically susceptible individuals lasts months to years then
transitions to a clinical RA event by virtue of other driving
factors [2]. These driving factors are currently poorly
understood, but it is suspected that microvascular, neuro-
regulatory, microtrauma-related, or transient infection-
dependent pathways are involved [2, 3].
We are interested in determining whether respiratory
viral infections have the capacity to driving RA develop-
ment, for several reasons. Smoking, periodontitis, and
microbiomes—all prominent environmental risk factors
for RA—interact with mucosal surfaces including the
lungs, oral mucosa, and gastrointestinal tract [4]. It is
thought that these local tissue stresses on the mucosa
lead to post-translational modification of peptides in-
volved in RA pathogenesis [2, 5, 6]. Initial respiratory
virus infections usually involve both the oral mucosa
and the lungs, and this may be relevant to the generation
of immune responses potentially associated with RA
development. Previous studies suggest that RA exhibits
seasonal tendencies, whereby RA onset is more frequent
in winter [7], and relapses are more frequent in summer
[8]. Thus, we hypothesized that respiratory viral infec-
tions that exhibit seasonality may be associated with RA
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development. This hypothesis is supported by studies in-
vestigating other autoimmune diseases [9–17]. Multiple
sclerosis which exhibits seasonal tendencies has been as-
sociated with upper respiratory picornavirus, rhinovirus,
and influenza infections [9–15]. Influenza virus infec-
tions triggered disease in a genetic model of experimen-
tal autoimmune encephalomyelitis [16]. Furthermore,
the occurrence of pediatric Henoch-Schönlein purpura
was highest in the spring and lowest in the summer, and
it was associated with an outbreak of influenza [17].
A few studies have investigated a potential link between
respiratory viral infections and the development of RA
[18, 19]. In the population-based case-control study, previ-
ous respiratory tract infections including sinusitis and ton-
sillitis treated with antibiotics, and pneumonia showed no
association with a risk of RA [18]. In this study, it is not
certain whether respiratory infections were caused by vi-
ruses or bacteria, but rather bacterial respiratory infections
seemed to be considered more. Another study, however,
showed that viral infection symptoms confirmed by ques-
tionnaire were more frequent in patients with a new-onset
RA in the previous year compared to healthy control, but
this was a small-sized study using 59 RA patients and 69
controls [19].
Reliable data reflecting respiratory viral epidemic burden
in South Korea are available, because the Korea Centers for
Disease Control and Prevention (KCDC) operates a well-
established surveillance system for the detection of respira-
tory viruses via polymerase chain reaction (PCR) diagnosis
in patients with respiratory symptoms [20, 21]. In addition,
population-based incident RA can be identified via claims
data because the Korean National Health Insurance (KNHI)
covers almost the entire South Korean population.
In the present study, the effects of ambient respiratory
viral infections on the number of incident RA in South
Korea were investigated using national public data. First,
patterns of incident RA over time were investigated
using claims data. A time-series analysis was then con-
ducted to investigate associations between the detection
rate of ambient respiratory viral infections and the
number of incident RA.
Methods
Study design and data source
This is an ecological study design, and we used records
from the KNHI claims database from 2011 to 2015. Pa-
tients’ diagnoses recorded via the International Statistical
Classification of Diseases and Related Health Problems
10th Revision (ICD-10), procedures, prescriptions, type of
institution or department, and individual beneficiary
information were provided [22]. The protocol utilized
in the present study was approved by the Institutional
Ethics Review Board of St. Vincent’s Hospital, Catholic
University of Korea.
Incident RA
The algorithm for identifying RA using claims has been
previously validated in Korea [23] and was recently up-
dated by Won et al. [24]. In accordance with Won et al.
[24], we selected individuals aged ≥ 19 years with claims
data pertaining to RA (ICD-10 codes M05 or M06). RA
was deemed to be confirmed in cases in which a pre-
scription for disease-modifying antirheumatic drugs was
issued within 1 year of the RA code being assigned. Inci-
dent RA, which means new RA cases, has to be fulfilled
1-year window period (no codes or prescriptions for RA)
and three consecutive years of treatment. Weekly num-
ber of incident RA was calculated from the first week of
January 2012 to the last week of December 2013.
Respiratory virus data
KCDC posts the incidences of respiratory virus infec-
tions each week on their website (http://cdc.go.kr) [20].
Nasopharyngeal specimens from patients with acute re-
spiratory infections are collected from 36 sentinel hospi-
tals located nationwide and subjected to respiratory viral
genetic testing via multiplex PCR. Target viruses include
influenza, parainfluenza, adenovirus, respiratory syncytial
virus (RSV), rhinovirus, coronavirus, metapneumovirus,
and bocavirus.
The detection rate of respiratory virus was calculated
as a proportion of patients who are confirmed for viral
infection by PCR among those with acute respiratory
viral infection symptoms who visited sentinel hospitals.
Because we hypothesized that respiratory viral infections
would exhibit a delayed association with incident RA
rather than an immediate effect, the detection rates of
eight respiratory viruses were collected from the first
week of November 2011, which is 8 weeks prior to the
start date of the collection of incident RA data, to the
last week of December 2013.
Environmental factors as potential confounders
Data pertaining to the potentially confounding factors
with regard to the viral detection rates and RA diagnoses
were obtained from public websites. We obtained hourly
air pollution data including particulate matter < 10 μg/
m3 in aerodynamic diameter (PM10) and ozone (O3)
from the website airkorea.gov.kr [25], operated by the
Korean Ministry of Environment. Meteorological data
reflecting hourly measurements of temperature, humid-
ity, and solar radiation were obtained from the website
maintained by the Korea Meteorological Administration
[26]. The hourly mean of all variables was calculated by
using obtained raw data in each station and converted
to daily means. Next, the daily metrological data were
converted into weakly means, then these means were
analyzed in conjunction with the respiratory viral
infection data. As with the respiratory viral detection
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rate data, the meteorological data were collected from
the first week of November 2011 to the last week of
December 2013.
Subgroup analysis
To identify the groups who were significant to the effects
of ambient respiratory viral infections on the number of
incident RA, a subgroup analysis was conducted based on
age, sex, and the presence or absence of respiratory
disease prior to RA development. Age groups were catego-
rized as < 40 years, 40–59 years, and ≥ 60 years based on
previously reported definitions of young-onset and eld-
erly-onset RA [27]. The presence of respiratory diseases
was defined as cases with respiratory disease codes during
the 12months prior to RA diagnosis. Respiratory disease
codes were extracted from ICD-10 codes (I27.8, I27.9,
J40.x-J47.x, J60.x-J67.x, J68.4, J70.1, J70.3) for Charlson
comorbidity index analysis [28].
Statistical analysis
Because respiratory virus data are provided by the source
as nationwide totals, all other data were analyzed as na-
tionwide totals. First, generalized additive modeling
(GAM) with integrated smoothness estimation was used
to investigate the relationships between detection rates
of eight respiratory viruses and the numbers of incident
RA cases. Generalized linear modeling (GLM) was then
used to estimate the effects of eight respiratory viruses
on the numbers of incident RA cases after adjusting for
potential confounders.
Degrees of freedom (df) for each confounding factor
was determined based on the unbiased risk estimation
derived from the GAM. Potential confounders used in
the model were PM10 with 9 df, O3 with 9 df, mean
temperature with 8 df, mean humidity with 9 df, solar
radiation with 9 df, and the natural cubic splines (ns) of
time trend with 4 df per year (4 df × 2 years = 8 df). To
consider delayed and cumulative effects of respiratory
viral infections on incident RA, we used the moving
average lag up to eight lag weeks (lag1–8). For example,
“lag1–8” refers to a moving average lag model for re-
spiratory viral infections over the previous 8 weeks. Con-
founder lag weeks were also matched with those of each
virus in GLM. To determine the greatest respiratory
viral effect on incident RA, we selected the lag associated
with the highest beta for each virus then analyzed the
statistical significance of the effect size at the selected
lag week in each virus.
SAS statistical software (version 9.4, SAS, Cary, NC,
USA) was used for data collation. All statistical analyses
were performed using R software (version 3.5.1, The R
Project for Statistical Computing, www.r-project.org). A
P value < .05 was considered statistically significant.
Results
Baseline characteristics
From January 2012 to December 2013, the total number
of patients newly diagnosed with RA was 24,117. Of
these, 18,688 (77.5%) were females, and the mean age at
RA diagnosis was 54.7 (SD 13.2) years (Table 1). Almost
all patients (95.0%) had a national health insurance. The
proportion of institutions that reported patients who
were diagnosed with a new RA was 44.6%, 23.8%, and
31.6% in clinics, general hospitals, and tertiary hospitals,
respectively (Additional file 1: Table S1).
Seasonal tendency of incident RA
The analysis revealed a seasonal tendency of incident RA
in each year (Fig. 1). In 2012, the number of incident RA
increased from January (n = 781) to July (n = 1274) then
decreased to December (n = 775) (Additional file 1:
Table S2). July had the highest number of incident RA
cases, and December had the lowest. We observed a
similar seasonality in 2013. In that year, the number of
incident RA cases increased from January (n = 1057) to
July (n = 1212) then decreased to December (n = 853).
The differences in the weekly mean number of incident
RA cases were compared between the top peaks in July
and other months. A significantly lower number of
weekly incident RA cases were observed from September
to February in both 2012 and 2013 (Additional file 1:
Table S2). Men and women showed the same seasonal
pattern for the number of incident RA (Additional file 1:
Figure S1).
Table 1 Characteristics of patients newly diagnosed with
rheumatoid arthritis in 2012 or 2013
Clinical values Patients (n = 24,117)
Age
Overall mean ± SD (years) 54.7 ± 13.2
Age group frequencies (n and %)
19–39 years 3174 (13.2%)
40–59 years 12,332 (51.1%)
≥ 60 years 8611 (35.7%)
Sex (n and %)
Women 18,688 (77.5%)
Men 5429 (22.5%)
Previous respiratory diseases (n and %)
Absence 14,273 (59.18%)
Presence 9844 (40.82%)
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Effects of respiratory viral infections on incident RA
Most viruses showed seasonal tendencies between 2012
and 2013 (Additional file 1: Figure S2). Outbreaks of
parainfluenza virus and bocavirus tended to occur in late
spring and early summer. RSV tended to be diagnosed
in the autumn. Outbreaks of influenza occurred in
winter, and coronavirus tended to be diagnosed from
November to December. Rhinovirus was prevalent from
spring to autumn, but only exhibited an outbreak in the
autumn of 2012, not in the autumn of 2013. Metapneu-
movirus was infrequent but tended to be diagnosed in
late winter and spring. Adenovirus did not exhibit any
seasonal tendencies.
The associations between the detection rate of respi-
ratory viral infections and the number of incident RA
were investigated using GAM. At lag1w, fluctuations in
associations were observed for all viruses except boca-
virus (Additional file 1: Figure S3). As the lag structure
changed from lag1w to lag1–8w, however, the fluctua-
tions in the associations gradually disappeared and the
association became more apparent and more linear for
some viruses. This suggests that ambient respiratory
viral infections are associated with an increased number
of incident RA after a moderate time interval, rather
than having an immediate effect.
Three viruses were significantly associated with the
number of incident RA in time-series analysis (Table 2).
The number of incident RA increased by 4.8% with an
incremental increase of 1% in the parainfluenza virus
detection rate at lag1–7w (P = 0.003). At lag1–6w,
coronavirus and metapneumovirus were associated with
respective increases in the number of incident RA of
Fig. 1 Incident rheumatoid arthritis trends in 2012 and 2013. The x-axis represents the study period from 2012 to 2013. Because respiratory virus
data (exposure) are provided weekly, the number of incident RA cases (outcome) is also represented weekly from the first week of January 2012
to the last week of December 2013. The y-axis represents the weekly number of incident RA cases in each week
Table 2 The effects of ambient respiratory virus on incident RA
Virus Percent change in incident
RA per 1-unit change in
the detection rate of virusa
95% CI P value
Adenovirus at lag1–6w 1.93 − 1.14 to 5.09 .220
Parainfluenza virus at lag1–7w 4.80 1.57 to 8.14 .003
Respiratory syncytial virus at lag1w − 0.06 − 0.82 to 0.71 .873
Influenza virus at lag1–6w 0.42 − 0.68 to 1.53 .446
Corona virus at lag1–6w 9.20 3.85 to 14.82 < .001
Rhinovirus at lag1–8w 1.54 − 2.19 to 5.42 .423
Bocavirus at lag1–8w 13.33 − 1.57 to 30.48 .082
Metapneumovirus at lag1–6w 44.02 1.98 to 103.39 .038
The moving average lag up to 8 lag weeks (lag1–8) was used in the analysis. For example, “lag1–8” refers to a moving average lag model for respiratory viral
infections over the previous 8 weeks
CI confidence interval
aRelative risk adjusted for mean particulate matter < 10 μg/m3 in aerodynamic diameter, ozone, temperature, humidity, amount of solar exposure, and seasonality
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9.2% (P < .001) and 44.0% (P = 0.038) with an incremen-
tal increase of 1% in virus detection rate. The visualized
associations with integrated smoothness estimation of
these respiratory viruses are shown in Fig. 2a–c.
Subgroup analysis
In women, all three viruses were significantly associated
with incident RA (P < .05), but in men, only parainflu-
enza virus was (P = 0.019) (Table 3). Elderly-onset RA in
patients aged ≥ 60 years was significantly associated with
all three viruses (P < .05). Only parainfluenza virus was
significantly associated with incident RA in patients aged
under 40 years (P = 0.034), and in patients aged 40–59
years, none of the three viruses was significantly
associated with incident RA. The presence or absence of
preexisting respiratory diseases showed a different
association with each virus; that is, coronavirus was only
associated with the number of incident RA cases in the
absence of other respiratory conditions, while metapneu-
movirus showed the opposite results, i.e., a significant
association (79.18% change in risk per 1-unit change in
exposure, P = 0.034) in the presence of a respiratory dis-
ease, but not in disease absence (23.87% change in risk
per 1-unit change in exposure, P = 0.352).
Discussion
The idea of infections acting as a trigger for the develop-
ment of RA has been suggested for a quite long time
without much clarification. In this study, the number of
weekly incident RA cases exhibited an inverted U-
shaped seasonal tendency throughout each year. In
addition, the detection rate for ambient respiratory viral
infections in the population was associated with an
increased number of incident RA cases, which suggests a
possible role for respiratory infections as a trigger for
the development of RA.
Seasonal tendencies of RA onset or relapse have been
evaluated in a small number of studies. In an Italian
study including 44 RA patients, there was no seasonal
tendency [29]. In the UK between 1957 and 1963, 43 of
the 100 patients had reported that RA occurred during
the winter [7]. In a more recent study using data from
the year 2000 in Israel, RA relapse occurred mostly dur-
ing the summer [8]. These studies were conducted many
years ago with small study groups. Advances in the un-
derstanding of RA and in diagnostic tools have since
changed the reported characteristics of patients with RA.
Thus, there is a need to reevaluate seasonal patterns of
RA using recent data derived from large groups.
In the present study, population-based incident RA
diagnoses in 2012 and 2013 were used, which is more
reliable. Notably, however, observations pertaining to
the seasonality of RA in the study should be interpreted
with caution. The index date of incident RA is not the
date of onset, rather it is the date that RA is diagnosed
by physicians. The onset of RA may precede its diagno-
sis by several weeks or months [30]. Nevertheless, a
distinct seasonal pattern of incident RA determined
based on the date of diagnosis could be explained by the
role of respiratory viral infections in inflammation.
Respiratory viral infections may play a role in the exacer-
bation of inflammation involving joints in patients with
subclinical or early-stage RA, prompting patients to visit
the hospital.
Several mechanisms of virus-induced initiating or
triggering of autoimmune disease have been suggested
[31, 32]: (1) “Molecular mimicry” is the most widely
proposed mechanism and occurs when a virus antigen
mimics a host antigen and activates cross-reactive T
cells. (2) “Epitope spreading” is another potential
mechanism. Tissue damage resulting from virus-specific
T cell activation or direct virus-mediated host tissue
destruction causes de novo activation of autoreactive T
Fig. 2 Effects of ambient respiratory viral infections on incident RA. Parainfluenza (a), coronavirus (b), and metapneumovirus (c) infection. The
x- and y-axes represent the weekly virus detection rate as a percentage and difference from the mean log relative risk of incident RA, respectively.
Solid lines represent the associations between the weekly virus detection rate and weekly number of incident RA cases, and the gray area
represents 95% confidence intervals for the risk
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cells and releases self-antigens into the inflammatory
environment. (3) “Bystander activation” is the activ-
ation of autoreactive T cells as a result of the release
of cytokines during a virus-targeted immune response.
(4) Encrypted host antigens are released from certain
tissues during virus-targeted tissue damage. (5)
“Superantigens” activate a wide range of nonspecific T
cell clones regardless of their specificity. In this study,
however, we could only reveal the association
between respiratory viruses and incident RA, but not
investigate the possible mechanisms as this is an
ecological study.
In our study, parainfluenza, coronavirus, and meta-
pneumovirus were significantly associated with the num-
ber of incident RA. The patterns of virus seasonality, the
severity or virulence of infections, and the parameters
such as peak age of viral infections have differential
effects on the associations between each respiratory virus
and incident RA. The similarity of the three significant
respiratory viruses in the study has not been elucidated
Table 3 The effects of ambient respiratory virus on incident RA in subgroups of patients
Subgroup Percent change in incident
RA per 1-unit change in
the detection rate of virusa
95% CI P value
Sex
Men
Parainfluenza virus at lag1–7w 8.24 1.34, 15.61 .019
Corona virus at lag1–6w 0.20 − 9.77, 11.28 .971
Metapneumovirus at lag1–6w − 5.11 − 58.96, 75.59 .659
Women
Parainfluenza virus at lag1–7w 3.82 0.18, 7.59 .040
Corona virus at lag1–6w 12.11 5.87, 18.71 < .001
Metapneumovirus at lag1–6w 67.4 13.04, 147.88 < .001
Age
< 40 years
Parainfluenza virus at lag1–7w 10.02 0.73, 20.17 .034
Corona virus at lag1–6w 7.97 − 6.31, 24.43 .289
Metapneumovirus at lag1–6w 45.89 − 43.27, 275.18 .433
40–59 years
Parainfluenza virus at lag1–7w − 0.11 − 4.38, 4.35 .962
Corona virus at lag1–6w 5.64 − 1.50, 13.3 .124
Metapneumovirus at lag1–6w 5.52 − 34.93, 71.09 .828
≥ 60 years
Parainfluenza virus at lag1–7w 10.66 4.96, 16.67 < .001
Corona virus at lag1–6w 14.64 5.41, 24.67 .001
Metapneumovirus at lag1–6w 118.19 22.19, 289.61 .008
Previous respiratory disease
Without respiratory disease
Parainfluenza virus at lag1–7w 4.48 0.26, 8.87 .037
Corona virus at lag1–6w 10.61 3.58, 18.11 .003
Metapneumovirus at lag1–6w 23.87 − 21.09, 94.47 .352
With respiratory disease
Parainfluenza virus at lag1–7w 5.66 0.61, 10.97 .028
Corona virus at lag1–6w 6.72 − 1.43, 15.53 .108
Metapneumovirus at lag1–6w 79.18 4.52, 207.16 .034
The moving average lag up to 8 lag weeks (lag1–8) was used in the analysis. For example, “lag1–8” refers to a moving average lag model for respiratory viral
infections over the previous 8 weeks
CI confidence interval
aRelative risk adjusted for mean particulate matter < 10 μg/m3 in aerodynamic diameter, ozone, temperature, humidity, amount of solar exposure, and seasonality
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by one of the factors described above. More complex
interactions among these virus factors or other environ-
mental factors may be involved.
Regarding the confounding factors, we adjusted for
meteorological factors and air pollution data, which
could affect the seasonality of the number of incident
RA cases. Considering the unmeasured confounders
associated with seasonality, we also adjusted the time
trend in the generalized linear model to avoid overesti-
mation of the effects of respiratory viral infection on the
number of incident RA cases. Nevertheless, other factors
that could explain why the number of incident RA cases
increased in July could exist. This point indicates we
should be cautious in interpreting these results.
It was interesting that the effects of ambient respira-
tory viral infections in the population on the number of
incident RA differed according to sex, although men and
women showed the same seasonal pattern for the
number of incident RA cases. Only the parainfluenza
virus was significant in men while all three viruses were
significant in women. The relatively small sample size of
men might have affected this difference. Also, a stronger
immune response in women could affect this difference
[33]. Stronger immunity to pathogens in women is asso-
ciated with lower viral loads and lower prevalence of in-
fections than in men, but it may also be associated with
increased severity of disease symptoms [34]. For ex-
ample, HIV-positive women tend to exhibit less circulat-
ing HIV RNA than HIV-positive men, but they are
reportedly at a 1.6-fold higher risk of developing AIDS
[35]. Fatality following exposure to pathogenic influenza
A viruses is higher in women [36, 37]. It may be that re-
spiratory viral infections result in stronger inflammation
in women than in men, and trigger stronger immune
responses, and this results in a differential proportion of
incident RA in women and men. However, the virus data
in relation to sex was not available for analysis in the
present study.
Viral arthritis is distinct from autoimmune disease-as-
sociated polyarthritis. Viral arthritis is usually self-limit-
ing, and treatment with immunosuppressants is usually
not required [38]. To exclude viral arthritis in the
present study, only individuals who underwent treatment
for 3 years were included. Additionally, treatment was
required to include immunosuppressants. Thus, the
seasonal tendency of RA diagnosis and the association
between ambient respiratory viral infections in the popu-
lation and incident RA in the study are unlikely to be an
effect of transient viral arthritis.
The current study had some limitations. A causal asso-
ciation between ambient respiratory viral infections in
the population and incident RA could not be proven
because this is an ecological study where it is not known
whether the individuals with RA also had viral
infections. A clear causal association between respiratory
viral infections and RA development remains to be
proven via future individual-level data study. In addition,
many respiratory viral infections, especially in the case
of mild symptoms, would not have been detected at hos-
pitals, hence would not have been listed in the nation-
wide database. Further study including all the patients
with acute respiratory infection symptoms, not based on
PCR, confirmed infection would also be valuable when
investigating possible associations between respiratory
infections and RA development.
Conclusions
In the present study, RA development exhibited a sea-
sonal tendency, and ambient parainfluenza, coronavirus,
and metapneumovirus infections were associated with
an increased number of incident RA. These results
support the etiological hypothesis that respiratory viral
infections in the population may have the capacity to
trigger RA.
Additional file
Additional file 1: Table S1. Payer type and institutions of patients
newly diagnosed with rheumatoid arthritis in 2012 or 2013. Table S2.
Monthly and weekly number of Incident RA. Figure S1. Incident
rheumatoid arthritis trends according to sex in 2012 and 2013. Figure S2.
The weekly detection rate of eight respiratory virus in 2012 and 2013.
Figure S3. Risks of incident RA associated with infection with eight
respiratory viruses over 8 lag weeks. (DOCX 1539 kb)
Abbreviations
df: Degrees of freedom; GAM: Generalized additive modeling;
GLM: Generalized linear modeling; ICD-10: International Statistical
Classification of Diseases and Related Health Problems 10th Revision;
KCDC: Korea Centers for Disease Control and Prevention; KNHI: Korean
National Health Insurance; ns: Natural cubic splines; O3: Ozone;
PCR: Polymerase chain reaction; PM10: Particulate matter < 10 μg/m3 in
aerodynamic diameter; RA: Rheumatoid arthritis; RSV: Respiratory syncytial
virus
Acknowledgements
We thank Mrs. Hyunkyung Park for the help in the analysis of this manuscript.
Authors’ contributions
YBJ, Y-HL, and Y-JP were responsible for the study conception and design.
YBJ and Y-HL were responsible for the acquisition of the data. YBJ, Y-HL,
K-JK, and Y-JP were responsible for the analysis and interpretation of the
data. All authors were involved in drafting the article critically for important
intellectual content, and all authors approved the final version to be published.
Dr. Park had full access to all data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis.
Funding
None
Availability of data and materials
The datasets generated and/or analyzed during the current study are
available in the KNHI and KCDC at the KCDC website (http://www.cdc.go.kr/
CDC/info/CdcKrInfo0502.jsp?menuIds=HOME006-MNU3003-MNU2953,
available in Korean).
Joo et al. Arthritis Research & Therapy          (2019) 21:199 Page 7 of 8
Ethics approval and consent to participate




The authors declare that they have no competing interests
Author details
1Division of Rheumatology, Department of Internal Medicine, St. Vincent’s
Hospital, College of Medicine, The Catholic University of Korea, Seoul,
Republic of Korea. 2Institute of Environmental Medicine, Seoul National
University Medical Research Center, Seoul, Republic of Korea. 3Environmental
Health Center, Seoul National University College of Medicine, Seoul, Republic
of Korea.
Received: 20 March 2019 Accepted: 16 August 2019
References
1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature.
2003;423:356–61.
2. Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis.
Immunity. 2017;46:183–96.
3. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J
Med. 2011;365:2205–19.
4. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a
review. Jama. 2018;320:1360–72.
5. Catrina AI, Ytterberg AJ, Reynisdottir G, Malmstrom V, Klareskog L. Lungs,
joints and immunity against citrullinated proteins in rheumatoid arthritis.
Nat Rev Rheumatol. 2014;10:645–53.
6. Kallberg H, Ding B, Padyukov L, Bengtsson C, Ronnelid J, Klareskog L,
Alfredsson L. Smoking is a major preventable risk factor for rheumatoid
arthritis: estimations of risks after various exposures to cigarette smoke.
Ann Rheum Dis. 2011;70:508–11.
7. Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of
rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.
Br Med J. 1973;2:96–100.
8. Rozin A, Balbir-Gurman A, Schapira D. Seasonal distribution of relapse onset
in rheumatoid arthritis and spondyloarthropathy: the possible effect of the
solar factor. Clin Exp Rheumatol. 2003;21:161–9.
9. Jin Y, de Pedro-Cuesta J, Soderstrom M, Stawiarz L, Link H. Seasonal
patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci.
2000;181:56–64.
10. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D,
Woodbaker R, Nunez M, Dwyer T, Taylor BV, et al. Monthly ambient sunlight,
infections and relapse rates in multiple sclerosis. Neuroepidemiology.
2008;31:271–9.
11. De Keyser J, Zwanikken C, Boon M. Effects of influenza vaccination and
influenza illness on exacerbations in multiple sclerosis. J Neurol Sci.
1998;159:51–3.
12. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Clinical relapses
and disease activity on magnetic resonance imaging associated with viral
upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg
Psychiatry. 1998;64:736–41.
13. Oikonen M, Laaksonen M, Aalto V, Ilonen J, Salonen R, Eralinna JP, Panelius
M, Salmi A. Temporal relationship between environmental influenza A and
Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.
Multiple sclerosis. 2011;17:672–80.
14. Kriesel JD, White A, Hayden FG, Spruance SL, Petajan J. Multiple sclerosis
attacks are associated with picornavirus infections. Multiple Sclerosis.
2004;10:145–8.
15. Kriesel JD, Sibley WA. The case for rhinoviruses in the pathogenesis of
multiple sclerosis. Multiple Sclerosis. 2005;11:1–4.
16. Blackmore S, Hernandez J, Juda M, Ryder E, Freund GG, Johnson RW,
Steelman AJ. Influenza infection triggers disease in a genetic model of
experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A.
2017;114:E6107–e6116.
17. Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in
pediatric Henoch-Schonlein purpura and comparison with outbreak of
infectious diseases. Medicine. 2018;97:e12217.
18. Sandberg ME, Bengtsson C, Klareskog L, Alfredsson L, Saevarsdottir S.
Recent infections are associated with decreased risk of rheumatoid arthritis:
a population-based case-control study. Ann Rheum Dis. 2015;74:904–7.
19. Arleevskaya MI, Shafigullina AZ, Filina YV, Lemerle J, Renaudineau Y.
Associations between viral infection history symptoms, granulocyte reactive
oxygen species activity, and active rheumatoid arthritis disease in untreated
women at onset: results from a longitudinal cohort study of Tatarstan
women. Front Immunol. 2017;8:1725.
20. http://www.cdc.go.kr/CDC/info/CdcKrInfo0502.jsp?menuIds=HOME006-
MNU3003-MNU2953. Accessed 21 Dec 2018.
21. Kim JM, Jung HD, Cheong HM, Lee A, Lee NJ, Chu H, Lee JY, Kim SS, Choi
JH. Nation-wide surveillance of human acute respiratory virus infections
between 2013 and 2015 in Korea. J Med Virol. 2018;90:1177–83.
22. Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review
and Assessment Service National Patient Samples. Epidemiol Health.
2014;36:e2014008.
23. Sung YK, Cho SK, Choi CB, Bae SC. Prevalence and incidence of rheumatoid
arthritis in South Korea. Rheumatol Int. 2013;33:1525–32.
24. Won S, Cho SK, Kim D, Han M, Lee J, Jang EJ, Sung YK, Bae SC. Update on
the prevalence and incidence of rheumatoid arthritis in Korea and an
analysis of medical care and drug utilization. Rheumatol Int. 2018;38:649–56.
25. https://www.airkorea.or.kr/index. Accessed 21 Dec 2018.
26. http://www.kma.go.kr/. Accessed 21 Dec 2018.
27. Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset
rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis.
2006;65:1226–9.
28. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders
LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining
comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care.
2005;43:1130–9.
29. Cimmino MA, Caporali R, Montecucco CM, Rovida S, Baratelli E, Broggini M.
A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis.
1990;49:521–3.
30. van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R,
Huizinga TW, van der Helm-van Mil AH. Long-term impact of delay in
assessment of patients with early arthritis. Arthritis Rheum. 2010;62:3537–46.
31. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role
of viruses in initiation, perpetuation, and progression of T-cell-mediated
autoimmune disease. Viral Immunol. 2001;14:227–50.
32. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy
Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, et al. The mosaic of
autoimmunity: hormonal and environmental factors involved in
autoimmune diseases--2008. Isr Med Assoc J. 2008;10:8–12.
33. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev
Immunol. 2016;16:626–38.
34. vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis.
PLoS Pathogens. 2016;12:e1005374.
35. Griesbeck MAM. Sex differences in the manifestations of HIV-1 infection. In:
Klein SL, Roberts CW, editors. Sex and gender differences in infection and
treatments for infectious diseases. Switzerland: Springer International
Publishing; 2015. p. 103–81.
36. Abadom TR, Smith AD, Tempia S, Madhi SA, Cohen C, Cohen AL. Risk
factors associated with hospitalisation for influenza-associated severe acute
respiratory illness in South Africa: a case-population study. Vaccine.
2016;34:5649–55.
37. Klein SLPA, Passaretti C, Anker M, Olukoya P. Sex, gender and influenza.
Geneva: World Health Organization; 2010.
38. Marks M, Marks JL. Viral arthritis. Clin Med. 2016;16:129–34.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Joo et al. Arthritis Research & Therapy          (2019) 21:199 Page 8 of 8
